Dana worked with Jerry at the NIH and used an early version of bioinformatics to define the control regions of genes coordinately regulated during the inflammatory response. This lead him to define the sequence GGGAATTCCC (PNAS 81:2313, 1984) which was later shown to bind NFkB. This same method defined the sequence that we later recognized as the HNF-1 binding sites. Dana joined the faculty of the University of North Carolina at Chapel Hill. He later founded Novalon and left the faculty of UNC to direct the company full-time. In June of 2000, he sold his company to Karo Bio. and joined their Board of Directors. Check the Wall Street Journal for details.